DIPYRIDAMOLE Gene Set

Dataset DGIdb Drug Targets 2026
Category physical interactions
Type drug
Description A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots. (Chemical Entities of Biological Interest Ontology, CHEBI_4653)
External Link https://dgidb.org/results?searchType=drug&searchTerms=DIPYRIDAMOLE
Similar Terms
Downloads & Tools

Genes

50 interacting proteins for the DIPYRIDAMOLE drug from theDGIdb Drug Targets 2026 dataset.

Symbol Name Standardized Value
PDE8B phosphodiesterase 8B 0.691921
PDE6H phosphodiesterase 6H, cGMP-specific, cone, gamma 0.518941
PDE8A phosphodiesterase 8A 0.518941
PDE6D phosphodiesterase 6D, cGMP-specific, rod, delta 0.518941
PDE6G phosphodiesterase 6G, cGMP-specific, rod, gamma 0.518941
PDE6B phosphodiesterase 6B, cGMP-specific, rod, beta 0.518941
PDE6A phosphodiesterase 6A, cGMP-specific, rod, alpha 0.345961
PDE7B phosphodiesterase 7B 0.345961
PDE6C phosphodiesterase 6C, cGMP-specific, cone, alpha prime 0.259471
PDE1B phosphodiesterase 1B, calmodulin-dependent 0.17298
PDE1A phosphodiesterase 1A, calmodulin-dependent 0.148269
PDE7A phosphodiesterase 7A 0.148269
PDE1C phosphodiesterase 1C, calmodulin-dependent 70kDa 0.148269
PDE9A phosphodiesterase 9A 0.129735
PDE5A phosphodiesterase 5A, cGMP-specific 0.122104
PDE2A phosphodiesterase 2A, cGMP-stimulated 0.11532
SLC29A4 solute carrier family 29 (equilibrative nucleoside transporter), member 4 0.0943529
ADA adenosine deaminase 0.0864902
TSG101 tumor susceptibility 101 0.0798371
SLC29A1 solute carrier family 29 (equilibrative nucleoside transporter), member 1 0.0741344
PDE3B phosphodiesterase 3B, cGMP-inhibited 0.0546254
PDE4A phosphodiesterase 4A, cAMP-specific 0.0536836
PDE3A phosphodiesterase 3A, cGMP-inhibited 0.0370672
ABCC1 ATP-binding cassette, sub-family C (CFTR/MRP), member 1 0.0324338
SLC2A4 solute carrier family 2 (facilitated glucose transporter), member 4 0.0309816
PDE4C phosphodiesterase 4C, cAMP-specific 0.0305259
RAPGEF3 Rap guanine nucleotide exchange factor (GEF) 3 0.0305259
CXCL8 chemokine (C-X-C motif) ligand 8 0.0259471
RAPGEF4 Rap guanine nucleotide exchange factor (GEF) 4 0.0220826
HSP90AB1 heat shock protein 90kDa alpha (cytosolic), class B member 1 0.0211813
PDE4B phosphodiesterase 4B, cAMP-specific 0.0170145
ALOX15B arachidonate 15-lipoxygenase, type B 0.0159674
PDE4D phosphodiesterase 4D, cAMP-specific 0.0150418
ATM ATM serine/threonine kinase 0.0123557
BRCA1 breast cancer 1, early onset 0.0112813
TSHR thyroid stimulating hormone receptor 0.0108113
THRB thyroid hormone receptor, beta 0.00969983
KAT2A K(lysine) acetyltransferase 2A 0.0081723
HSP90AA1 heat shock protein 90kDa alpha (cytosolic), class A member 1 0.00682817
DRD1 dopamine receptor D1 0.00570265
PLK1 polo-like kinase 1 0.00546254
USP1 ubiquitin specific peptidase 1 0.00487269
ATAD5 ATPase family, AAA domain containing 5 0.00351824
HSD17B10 hydroxysteroid (17-beta) dehydrogenase 10 0.00250092
CYP2C9 cytochrome P450, family 2, subfamily C, polypeptide 9 0.00238046
CYP2C19 cytochrome P450, family 2, subfamily C, polypeptide 19 0.00217585
GMNN geminin, DNA replication inhibitor 0.00215328
CYP2D6 cytochrome P450, family 2, subfamily D, polypeptide 6 0.00169866
EHMT2 euchromatic histone-lysine N-methyltransferase 2 0.00118751
CYP3A4 cytochrome P450, family 3, subfamily A, polypeptide 4 0.00117142